Skip to content

Alamar Biosciences

US · ALMR #2657 by market cap Listed 2026
26.48 -2.20 -7.67%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 14 in the most recent period (2026/Q3).
  • Total institutional ownership fell 7.4 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
65.10% -7.41pp
Institutions
125 +14
As of
2026/Q3 vs. prior period

Holder types

VC/PE Fund34.14%
Mutual Fund22.37%
Individual/Insider10.42%
Hedge Fund7.80%
Government Pension Fund0.33%
Public Company0.29%
Family Office/Trust0.11%
Other24.48%

Top holders as of 2026-11-03

Qiming Weichuang Venture Capital Management (Shanghai) Company Limited 13.09% · 9.10M sh
IIF Management Company LLC 9.16% · 6.36M sh
Zhuhai Sherpa Equity Investment Management Company Limited 6.90% · 4.80M sh
Sands Capital Management, LLC 6.09% · 4.23M sh
Sands Capital Alternatives, LLC 6.10% · 4.23M sh
Yuling Luo 4.44% · 3.09M sh
Lian Luo 4.29% · 2.98M sh
Samsara BioCapital LLC 3.57% · 2.48M sh
T. Rowe Price Group, Inc. 3.19% · 2.21M sh
Emerald Advisers, LLC 1.88% · 1.30M sh
Braidwell LP 1.56% · 1.08M sh
ARK Investment Management LLC 1.79% · 1.24M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 24 sells

NameRoleStake
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- 13.09%
Yuling Luo Chairperson & CEO 4.44%
Shiping Chen Co-Founder, COO & Director 1.04%
Timothy White President 0.65%
Nicholas Naclerio Independent Director --
Franklin Witney Lead Independent Director --
Robert Ragusa Director --
IIF Management Company LLC -- --
Justin McAnear Chief Financial Officer --
Rebecca Chambers Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-02 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -111,313 $29.89
2026-11-01 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -187,636 $29.84–33.31
2026-10-27 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -185,731 $30.33–33.11
2026-10-25 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -280,458 $29.35–31.07
2026-10-21 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -342,626 $29.00–30.81
2026-10-19 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -217,512 $26.34–28.44
2026-10-15 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Open Market Disposition -173,673 $27.02–28.26
2026-10-13 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Intent to Sell (Form 144) -1,558,858 $23.52
2026-10-13 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Intent to Sell (Form 144) -435,468 $23.52
2026-10-13 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Intent to Sell (Form 144) -363,729 $23.52
2026-10-13 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Intent to Sell (Form 144) -41,945 $23.53
2026-09-13 John Brottem General Counsel Other Acquisition +29,000 --
2026-09-13 John Brottem General Counsel Other Derivative Acquisition +85,000 $27.99
2026-08-31 Robert Ragusa Director Other Acquisition +5,686 --
2026-08-31 Robert Ragusa Director Other Derivative Acquisition +25,599 $29.36
2026-04-19 Nicholas Naclerio Independent Director Other Acquisition +5,686 --
2026-04-19 Franklin Witney Lead Independent Director Other Derivative Acquisition +206,781 $0.59–7.60
2026-04-19 Franklin Witney Lead Independent Director Other Derivative Disposition -206,781 $0.59–7.60
2026-04-19 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Other Acquisition +10,594,547 --
2026-04-19 Qiming Weichuang Venture Capital Management (Shanghai) Company Limited -- Derivative Exercise and Sale -10,594,547 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Alamar Biosciences discussion 0 comments

Add a comment